Literature DB >> 16493151

Pulmonary vasculitis.

Kevin K Brown1.   

Abstract

Pulmonary vasculitis describes a number of distinct disorders that are pathologically characterized by the destruction of blood vessels. The clinical manifestations of each disorder are defined by the size, type, and location of the affected vasculature. The clinical approach to these disorders rests upon an astute clinician considering the diagnosis and identifying the specific patterns of clinical, radiologic, laboratory, and pathologic abnormalities. Lung involvement is most commonly seen with the primary, idiopathic, small-vessel, or antineutrophil cytoplasmic antibody-associated vasculitides; Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome. However, primary, idiopathic medium and large-vessel vasculitis, primary immune complex-mediated vasculitis, and secondary vasculitis are all capable of presenting with lung involvement. In this article, we focus on the more common, antineutrophil cytoplasmic antibody-associated disorder, vasculitides.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493151      PMCID: PMC2658676          DOI: 10.1513/pats.200511-120JH

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  89 in total

Review 1.  Small vessel vasculitis of the lung.

Authors:  M I Schwarz; K K Brown
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

Review 2.  Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis.

Authors:  G Gaskin; C D Pusey
Journal:  Ther Apher       Date:  2001-06

3.  Successful treatment of diffuse alveolar hemorrhage with activated factor VII.

Authors:  David Henke; Ronald J Falk; Don A Gabriel
Journal:  Ann Intern Med       Date:  2004-03-16       Impact factor: 25.391

4.  Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.

Authors:  M Gayraud; L Guillevin; P le Toumelin; P Cohen; F Lhote; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  2001-03

5.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Authors:  E C Hagen; M R Daha; J Hermans; K Andrassy; E Csernok; G Gaskin; P Lesavre; J Lüdemann; N Rasmussen; R A Sinico; A Wiik; F J van der Woude
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

6.  Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions.

Authors:  Kimberly A Russell; Elaine Wiegert; Darrell R Schroeder; Henry A Homburger; Ulrich Specks
Journal:  Clin Immunol       Date:  2002-05       Impact factor: 3.969

7.  Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage.

Authors:  S Hinan Ahmed; Tariq Aziz; Joel Cochran; Kristin Highland
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

Review 8.  Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

Authors:  J G Lanham; K B Elkon; C D Pusey; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

9.  Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma.

Authors:  M E Wechsler; D Finn; D Gunawardena; R Westlake; A Barker; S P Haranath; R A Pauwels; J C Kips; J M Drazen
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

10.  Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis.

Authors:  J T Lie
Journal:  Arthritis Rheum       Date:  1990-08
View more
  29 in total

Review 1.  The lung in systemic vasculitis: radiological patterns and differential diagnosis.

Authors:  Beatrice Feragalli; Cesare Mantini; Marco Sperandeo; Michele Galluzzo; Giovanni Belcaro; Armando Tartaro; Antonio R Cotroneo
Journal:  Br J Radiol       Date:  2016-02-15       Impact factor: 3.039

2.  Wegener's granulomatosis.

Authors:  Mohamed Haris; Anastasios Koulaouzidis; Muneed Yasir; Stuart Clark; Musa Kaleem; Ramesh Mallya
Journal:  CMAJ       Date:  2008-01-01       Impact factor: 8.262

3.  A surprise behind a case of winter vomiting virus.

Authors:  Aikaterini Panopoulou; Erin Vermaak; Neil McHugh
Journal:  BMJ Case Rep       Date:  2013-07-22

4.  Isolated pauci-immune pulmonary capillaritis.

Authors:  Ashok Kumar Mehrotra; Prahlad Rai Gupta; Trilok Kumar Khublani; Shridha Soni; Asif Feroz
Journal:  Lung India       Date:  2015 Jan-Feb

Review 5.  Pulmonary vasculitis.

Authors:  Ana Casal; Juan Díaz-Garel; Tara Pereiro; María E Toubes; Jorge Ricoy; Luis Valdés
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 6.  Pulmonary vasculitis: diagnosis and endovascular therapy.

Authors:  Kiran Batra; Murthy Chamarthy; Rodrigo Caruso Chate; Kirk Jordan; Fernando Uliana Kay
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 7.  [Vasculitis in the trunk: Imaging patterns of typical organ manifestations due to primary vasculitis of small and medium sized vessels].

Authors:  H Strube; C Becker-Gaab; M Reiser; M Treitl
Journal:  Radiologe       Date:  2010-10       Impact factor: 0.635

8.  The enigma of vasculitis.

Authors:  Daniela Ghetie; Alla Rudinskaya; Raymond Raut
Journal:  Int J Rheumatol       Date:  2010-06-10

Review 9.  Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease.

Authors:  Timothy J Vece; Levi B Watkin; Sarah Nicholas; Debra Canter; Michael C Braun; R Paul Guillerman; Karen W Eldin; Grant Bertolet; Scott McKinley; Marietta de Guzman; Lisa Forbes; Ivan Chinn; Jordan S Orange
Journal:  J Clin Immunol       Date:  2016-04-05       Impact factor: 8.317

10.  Wegener's granulomatosis in which rheumatoid factor was useful for evaluating the disease status: a case report.

Authors:  Hideto Oshita; Hiromi Matsumoto; Teppei Hoshino; Keitaro Omori; Naoki Okamoto; Yukikazu Awaya
Journal:  Cases J       Date:  2009-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.